Biotech Kardigan gained nearly 2% in its stock market debut after completing a $400 million initial public offering that priced at the…
Kardigan's upsized $400 million IPO for heart disease therapies highlights growing investor confidence in biotech innovation and sets a favorable precedent for…
Manipal Hospitals plans a $1 billion July IPO, marking one of India's biggest healthcare listings amid a booming stock market and rising…
Parabilis stock skyrocketed 67% after the drugmaker completed a $745 million IPO and private placement, marking one of the largest biotech IPOs…
Chinese healthcare shares hit their cheapest valuation in history as an AI investment drain starves the sector of capital, sending the Hang…
European stocks fell as profit-taking and a sector rotation out of healthcare into banks weighed on benchmarks, highlighting cautious market sentiment.
Cancer drugmaker Parabilis aims to raise $475 million in a US IPO, testing biotech investor sentiment as the company progresses its oncology…
McKesson's unit took a $2.25 billion leveraged loan ahead of its IPO, a move that could indicate final steps toward the public…
Swiss dental startup vVardis, with its drill-free carie treatment, plans a U.S. IPO, signaling market confidence in dental tech innovations.
Scientists are tracking Ebola survivors in remote mountains to harvest antibodies for a cure, offering new hope against the virus and potential…
Apotex Health's planned C$1.2 billion Toronto IPO underscores strong demand for Canadian healthcare equities, with potential to lift the S&P/TSX Composite Index…
Big Caring, Malaysia’s top pharma retailer, targets a $750 million IPO, marking a major test for equity capital markets in the region.